# GPT-5.4 (R2) Review

**Role:** External referee review
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-26T15:43:34.115756
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 19386 in / 4827 out
**Response SHA256:** b8276d7ebf069cd0

---

This paper asks an important and policy-relevant question: how much economic incidence is driven by enforcement architecture rather than statutory text? The Illinois BIPA / *Rosenbach* setting is conceptually attractive because the court decision plausibly changed enforceability while leaving formal statutory language unchanged. The paper is also commendably transparent about two major threats—few clusters and a 2017–2018 pre-trend—that many papers would bury. Those are real strengths.

At the same time, in its current form the paper is not publication-ready for a top general-interest journal or AEJ:EP. The central empirical design is interesting but not yet credible enough for the stated causal claims, and the inferential framework is materially weaker than the headline results suggest. The current draft reads more like a promising first reduced-form pass than a finished paper.

## 1. Identification and empirical design

### Core design
The main specification is a continuous-exposure DDD:
\[
\log Y_{ijt} = \beta (\text{IL}_i \times \text{Post}_t \times \text{Exposure}_j) + \gamma_{ij} + \delta_t + \text{lower-order terms} + \varepsilon_{ijt}
\]
with county-sector and quarter fixed effects (Section 6).

In principle, this is a sensible design: compare more- vs less-exposed sectors in Illinois before/after *Rosenbach*, relative to analogous exposure gradients in neighboring states.

### Main identification concern: the paper does not establish a credible counterfactual trend
The paper itself documents the most serious problem: a significant placebo at 2017Q1 (+6.5%, Section 8 / Table 3) and event-study coefficients that are not flat in 2017–2018 (Section 6.3, Section 7.3). This is not a peripheral issue; it directly undermines the key identifying assumption that absent *Rosenbach*, exposure gradients would have evolved similarly in Illinois and neighboring states.

The draft tries to mitigate this by arguing that:
1. pre-2017 coefficients are flat,
2. the deviation may reflect anticipation,
3. dropping 2017–2018 still yields a negative estimate.

These points help, but they do not solve the problem.

- The anticipation story is speculative. Oral arguments in 2018 do not naturally explain differential growth beginning in 2017Q1.
- Trimming 2017–2018 is not innocuous. It changes the identifying variation and can mechanically strengthen a post-2019 break if 2017–2018 were already trending unusually.
- Calling the baseline an “upper bound” and the trimmed estimate a “lower bound” is not econometrically justified. Those are different estimands under different assumptions, not formal bounds.

For a top journal, the design must do more than acknowledge the pre-trend; it must either neutralize it or redesign around it.

### Border design: intuitive but not yet sufficiently disciplined
The border-county focus is sensible (Section 5.4, Section 6.2), but the current implementation does not exploit the border structure as tightly as it should.

The specification includes county-sector FE and common quarter FE, but not border-pair-by-time fixed effects. As written, identification comes partly from comparisons across different border regions and statewide shocks that may differ across Illinois’s Indiana, Wisconsin, Missouri, Iowa, and Kentucky border areas. For a border design, a stronger specification would absorb highly local shocks by comparing within border pairs over time. Without pair × time controls, the argument that opposite-side counties “share labor markets” is only partially implemented econometrically.

Relatedly, the paper does not show that results are strongest in integrated border labor markets where relocation is most plausible (e.g., Chicagoland-IN, St. Louis MO-IL) versus thin rural borders. That heterogeneity would materially improve credibility.

### Treatment timing and post-treatment contamination
The treatment period runs through 2024Q4 (Section 5.1), but the paper also notes major 2024 amendments (Section 3) that sharply reduced expected liability. Those amendments are themselves a policy shock affecting the treatment intensity. Pooling 2019Q1–2024Q4 into one undifferentiated post period risks conflating:
- activation of private enforcement in 2019,
- pandemic-era sectoral shocks,
- later legal maturation and settlement dynamics,
- partial rollback in 2024.

The paper says only two post-amendment quarters are available, but that is precisely why claims about persistent post-treatment dynamics should be restrained and why the preferred specification should likely end before the 2024 amendments or treat them explicitly.

### Exposure measure raises nontrivial design concerns
The biometric exposure index is innovative, but currently too ad hoc for the paper’s causal weight.

1. **Post-treatment construction**: the measure uses O*NET version 29.1 from March 2025 (Section 5.2). The paper argues occupational requirements are structural and unlikely to respond to Illinois litigation. Maybe—but this is not enough. For a continuous-treatment design, mismeasurement of exposure is central, and post-treatment construction weakens exogeneity.
2. **Keyword/classification subjectivity**: the draft does not provide enough replicable detail to evaluate whether the 301 “biometric-relevant” entries and 50 task statements are objective or researcher degrees of freedom.
3. **Ad hoc preemption adjustment**: applying a 60% discount to Finance and Healthcare (Section 5.2, Step 3) is a substantive modeling choice, not a minor adjustment. The paper gives no empirical basis for 60% versus, say, 30%, 80%, or zero. Since null effects in preempted sectors play a major interpretive role, this adjustment needs much more justification and sensitivity analysis.
4. **Potential endogeneity to broader technology intensity**: the paper argues nulls in Finance/Healthcare rule out a general technology-climate channel (Section 6.3), but since those sectors are manually discounted for preemption, the nulls are partly built into the measure. That weakens the placebo interpretation.

### Mechanism claims are too strong for the evidence
The paper presents geographic reallocation, scale compression, and technology substitution as adjustment margins (Section 4, Section 9). But the evidence only weakly speaks to these:
- “Geographic reallocation” is inferred mostly from attenuation in all-counties estimates relative to border estimates. That is consistent with reallocation, but also with local pre-trends, spillovers, compositional differences, or model misspecification.
- “Scale compression” is based on insignificant establishment-size estimates (Table 1).
- “Technology substitution” is explicitly unobserved.

These are at best hypotheses consistent with the reduced form, not mechanisms established by the data.

## 2. Inference and statistical validity

This is the paper’s second major weakness.

### The main conventional p-values are not reliable
The paper appropriately notes that with six state clusters, conventional cluster-robust inference is unreliable (Section 6.3, Section 8). Yet the draft still prominently reports stars and clustered p-values throughout the abstract, introduction, tables, and conclusion. That is internally inconsistent.

If the primary inferential frame is randomization inference, then the paper should lead with that throughout, not with “p < 0.001” from six-cluster CRVE. As written, the presentation overstates certainty.

### Randomization inference does not deliver strong evidence
The most credible inferential result reported is the timing-permutation p-value of 0.077 (Table 3; Identification Appendix). The state-permutation p-value is 0.167, i.e. not conventionally significant and also mechanically coarse because there are only six states.

For a paper making strong causal and policy-incidence claims, this is weak evidence. Marginal significance on one permutation dimension and null on the other is not fatal, but it requires much more restraint than the current draft shows.

### Sector-specific inference is especially fragile
Table 2 reports separate sector-level DiD estimates with state-clustered standard errors. But each of these regressions still has only six clusters, often with much smaller effective sample support due to suppression and thin sectors. These p-values are even less trustworthy than the pooled specification. Yet the paper uses them heavily to claim the effect “tracks the exposure gradient.”

For publication at this level, these sector-specific results need either:
- a unified hierarchical / interaction-based estimation with coherent randomization inference,
- or a more principled exposure-gradient test using all sectors jointly, rather than many thin separate regressions.

### Event-study inference is incomplete
The event-study figure is important because the design lives or dies on dynamics, but the paper does not report a formal joint pre-trend test, simultaneous confidence bands, or a robust inferential approach suited to six clusters. Visual claims that coefficients are “centered near zero” through mid-2017 are insufficient, especially given the significant placebo.

### Sample sizes and sample coherence
Most sample counts are transparent, but there are some issues:
- Table 1 uses 19,726 border observations; Table 4 notes sector observations sum to 19,737 and regressions use 19,726 after dropping singleton FE. Fine, but this should be handled more systematically across all tables.
- Sector regressions have different county support (Table 2), which complicates cross-sector comparisons. The paper should be clearer that sector effect differences may partly reflect changing composition and suppression rather than only treatment intensity.

## 3. Robustness and alternative explanations

### What the paper does well
The paper makes several sensible robustness efforts:
- pre-COVID subsample,
- trimmed window excluding 2017–2018,
- sector × quarter FE,
- leave-one-state-out,
- placebo timing,
- all-counties benchmark.

These are useful and should remain.

### But the current robustness set is not enough for the design’s vulnerabilities

#### A. Need stronger control for local shocks
The most important omitted robustness is a border-pair × time specification. Without it, local cross-border comparability is asserted more than demonstrated.

#### B. Need stronger treatment of pre-trends
Given the documented differential pre-trend, the paper should estimate designs that explicitly allow for differential Illinois × exposure pre-trends, or at least sector-specific Illinois trends, and show how sensitive the post coefficient is. Absent that, the reader cannot tell whether the negative post effect is just mean reversion after a positive Illinois-specific run-up in high-exposure sectors.

#### C. Exposure-index robustness is essential
The paper needs major sensitivity analysis around the exposure measure:
- raw O*NET exposure without preemption discounts,
- alternative preemption discount values,
- binary high/low exposure classifications,
- exposure excluding the IT-intensity component,
- leave-one-sector-out gradient tests,
- possibly externally validated exposure proxies (e.g., case filings, mentions of biometric timeclocks, vendor penetration, occupational fingerprint/facial recognition usage).

At present, too much of the result depends on one bespoke index.

#### D. Spillovers need actual evidence, not conjecture
Section 6.3 suggests control-side spillovers may bias estimates upward in absolute value. That is plausible, but the paper never directly shows positive effects in neighboring-state border counties. A proper mirror test—estimating exposed-sector growth on the non-Illinois side relative to interior non-Illinois counties—would be far more convincing than the current verbal discussion.

#### E. 2024 amendments should be handled explicitly
Because the paper’s theory is about enforcement intensity, a major statutory rollback is not a footnote. A cleaner main sample may be 2015Q1–2024Q2 or even 2015Q1–2024Q1, with post-amendment quarters reserved for exploratory analysis.

## 4. Contribution and literature positioning

The paper’s substantive contribution is potentially meaningful: separating enforcement architecture from statutory content is important and under-studied. The BIPA setting is also genuinely interesting.

That said, the literature positioning could be sharpened in two ways.

### First, the paper should engage more directly with modern DiD/event-study identification and inference literature
Given that the paper’s main challenge is not staggered timing but few clusters, border design, and pre-trends, the relevant methodological references should be broader and more current. At minimum, the paper should engage with work on:
- randomization/permutation inference in DiD and panels,
- wild cluster bootstrap / few-cluster inference,
- pre-testing and event-study interpretation,
- border designs with local controls.

Concrete references worth considering:
- Bertrand, Duflo, and Mullainathan (2004), for serial correlation in DiD.
- Cameron, Gelbach, and Miller (2008), for bootstrap-based inference with few clusters.
- MacKinnon and Webb (2017, 2020), on wild bootstrap and randomization inference with few treated clusters.
- Roth (2022), on pre-trends and the limits of pre-testing.
- Cattaneo, Idrobo, and Titiunik (2020) is less directly relevant here, but border-RD/local comparison literatures may help justify geographic designs if the authors move in that direction.

### Second, the policy-domain literature should include more on BIPA and privacy enforcement specifically
The paper cites broad privacy-regulation work, but the institutional argument would benefit from closer engagement with legal/economic work on BIPA litigation, statutory damages, class actions, and biometric technology adoption. Even if much of that literature is in law reviews or policy outlets, it matters here because the identification hinges on the legal mechanics of standing, preemption, and damages.

## 5. Results interpretation and claim calibration

This is where the paper most needs recalibration.

### Headline claims currently overreach the evidence
The abstract and introduction emphasize a “one-unit increase in exposure reduced employment by 11.7%,” with sector-specific corroboration. But the paper itself also tells us:
- the main robust inferential result is only RI p = 0.077 for timing permutations,
- state-permutation RI is 0.167,
- there is a significant positive pre-trend in 2017–2018,
- all-counties estimates are small and insignificant,
- mechanism evidence is mostly suggestive.

Given that, the current framing is too strong. The evidence supports something like:
> suggestive evidence that *Rosenbach* was followed by relative employment declines in more biometrically exposed sectors near Illinois borders, with magnitudes sensitive to pre-trend treatment and inference limited by the single-state setting.

It does not support strong statements that private enforcement “reduced employment by 11.7%” full stop.

### Border estimate vs aggregate effect
The paper is admirably candid that the all-counties estimate is -1.9% and insignificant (Table 1). That result substantially narrows the policy interpretation. If the effect is concentrated in border counties, then the paper may be documenting geographic reallocation rather than meaningful statewide job destruction. The current text sometimes acknowledges this, but the broader discussion still reads as though a large overall employment effect has been established.

### “Tracks the exposure gradient” is only partially shown
The exposure-gradient claim is plausible, but Table 2 is not as clean as the prose suggests:
- Administrative Services has exposure 0.97 and null effects;
- Education has a relatively large negative coefficient despite low exposure;
- Management is very large but based on thin support;
- the gradient appears noisy.

This is not fatal, but the text should reflect that the monotonicity is imperfect.

### Welfare discussion should be more restrained
The paper sometimes moves from reduced-form employment effects to language like “over-deterrence” and “litigation tax” in a way that sounds normative. Those concepts are useful heuristics, but without measuring compliance behavior, privacy benefits, or actual expected liability incidence, the paper cannot establish over-deterrence. It can show employment responses consistent with increased expected litigation risk.

## 6. Actionable revision requests

### 1. Must-fix issues before acceptance

#### 1. Rebuild the identification strategy around the documented pre-trend
- **Issue:** The 2017–2018 positive differential trend is a direct threat to causal identification.
- **Why it matters:** Without a credible counterfactual trend, the main coefficient is not interpretable as a causal post-*Rosenbach* effect.
- **Concrete fix:** Re-estimate with Illinois × exposure-specific linear trends or flexible pre-trend adjustments; report formal pre-trend tests; show sensitivity of estimates to trend controls; explore alternative event-study parameterizations; justify or abandon the anticipation interpretation unless supported with legal-timing evidence.

#### 2. Strengthen the border design econometrically
- **Issue:** Current border design does not absorb local border-region shocks.
- **Why it matters:** Claims of local comparability are central to the design.
- **Concrete fix:** Define border pairs or border commuting zones and include pair × quarter fixed effects (or a similarly local time-varying control structure). Show that results survive in the most integrated border markets.

#### 3. Make inference coherent and honest throughout
- **Issue:** The paper says conventional clustered p-values are unreliable but still foregrounds them.
- **Why it matters:** Statistical validity is a pass/fail issue.
- **Concrete fix:** Make RI or few-cluster-robust methods the main inferential basis everywhere (abstract, tables, text); add wild-cluster-bootstrap p-values if feasible; remove or de-emphasize stars based on six-cluster CRVE; provide robust inference for event studies and sector heterogeneity tests.

#### 4. Rework the exposure measure and its sensitivity
- **Issue:** The continuous treatment is bespoke, post-treatment, and includes an ad hoc 60% preemption discount.
- **Why it matters:** The identification rests on exposure variation; if the measure is unstable, so are the results.
- **Concrete fix:** Provide a full appendix on construction and validation; show results under multiple alternative exposure definitions; vary preemption discounts; show results with no discount; if possible, use pre-2019 occupational/technology data or external validation from BIPA case targets / biometric vendor data.

#### 5. Separate the 2024 amendments from the main post period
- **Issue:** Treatment intensity changes materially in 2024.
- **Why it matters:** Pooling over a partial rollback obscures interpretation.
- **Concrete fix:** Make pre-amendment results the main specification; treat post-2024Q3 observations separately or drop them from the preferred sample.

### 2. High-value improvements

#### 6. Provide direct spillover / mirror-image tests
- **Issue:** Reallocation to neighboring states is asserted rather than directly shown.
- **Why it matters:** Distinguishing destruction from reallocation is central to policy interpretation.
- **Concrete fix:** Test for exposed-sector gains in neighboring-state border counties relative to interior neighboring-state counties; show whether wages/employment rise on the control side.

#### 7. Replace separate sector regressions with a unified heterogeneity framework
- **Issue:** Table 2 relies on weak sector-by-sector inference.
- **Why it matters:** The exposure-gradient claim should not depend on many thin regressions with six clusters.
- **Concrete fix:** Estimate a pooled model with flexible exposure bins or sector-interaction terms and assess heterogeneity jointly using RI-compatible omnibus tests.

#### 8. Clarify what is mechanism evidence versus interpretation
- **Issue:** Mechanism claims outrun the data.
- **Why it matters:** Overstated mechanisms weaken credibility.
- **Concrete fix:** Reframe relocation, fragmentation, and substitution as hypotheses; if possible, add direct tests using establishment births/deaths, average size distributions, or cross-border firm movement.

#### 9. Tighten claim calibration throughout
- **Issue:** The abstract/introduction still sound stronger than the evidence warrants.
- **Why it matters:** Publication readiness depends on conclusions matching design strength.
- **Concrete fix:** Rephrase headline findings around “suggestive evidence,” emphasize the RI results and pre-trend caveat upfront, and distinguish border-local effects from statewide aggregate effects.

### 3. Optional polish

#### 10. Refine the legal-institutional justification of preemption
- **Issue:** GLBA/HIPAA preemption is treated too categorically in places and too loosely in others.
- **Why it matters:** These sectors are central placebo cases.
- **Concrete fix:** Add a clearer legal appendix documenting why and to what extent these sectors are shielded, and how that maps to the exposure coding.

#### 11. Better motivate sample selection and suppression effects
- **Issue:** Suppression and varying sector support may affect composition.
- **Why it matters:** Cross-sector comparisons can be distorted.
- **Concrete fix:** Report suppression patterns by sector/state/time and show they are not themselves affected by treatment.

#### 12. Moderate welfare language
- **Issue:** “Over-deterrence” is stronger than the evidence supports.
- **Why it matters:** Normative claims should track measured outcomes.
- **Concrete fix:** Frame welfare discussion as illustrative and conditional, not established.

## 7. Overall assessment

### Key strengths
- Important, under-studied question: enforcement design versus statutory content.
- Institutionally interesting setting with a sharp legal event.
- Creative continuous-exposure approach.
- Good transparency about major limitations, especially few clusters and pre-trends.
- Several sensible robustness exercises already in place.

### Critical weaknesses
- Identification is not yet credible due to the documented 2017–2018 pre-trend.
- Inference is materially weaker than the headline conventional p-values imply.
- Border design is not implemented tightly enough to justify its comparative claims.
- Exposure measure is too bespoke and insufficiently validated for the causal burden it carries.
- Interpretation overstates what the evidence can support, especially on magnitude, mechanism, and welfare.

### Publishability after revision
I think this is a promising paper, but not close to acceptance in its present form. The topic is strong enough that a substantially revised version could become publishable. However, the revisions required are not cosmetic; they involve redesigning the empirical strategy, reframing the inference, and substantially tightening claim calibration.

DECISION: MAJOR REVISION